Polaris Venture Management Co. V, L.L.C.

Insider Buys Quantity –
5
2020-05-05SaleLyra Therapeutics, Inc.
LYRA
10 percent owner
9,674
0.1136%
$16.00$154,784-28.92%
2020-05-05PurchaseLyra Therapeutics, Inc.
LYRA
10 percent owner
62,500
0.734%
$16.00$1M-28.92%
2019-12-17SalePhreesia, Inc.
PHR
10 percent owner
714,242
1.8667%
$24.48$17.48M+13.88%
2019-07-22SalePhreesia, Inc.
PHR
10 percent owner
793,598
8.7688%
$18.00$14.28M+13.72%
2019-07-17SaleCardlytics, Inc.
CDLX
10 percent owner
55,562
0.2345%
$27.45$1.53M+76.85%
2019-07-16SaleCardlytics, Inc.
CDLX
10 percent owner
41,924
0.1793%
$27.87$1.17M+76.17%
2019-07-15SaleCardlytics, Inc.
CDLX
10 percent owner
39,968
0.1701%
$27.73$1.11M+74.5%
2019-06-07SaleCardlytics, Inc.
CDLX
10 percent owner
200,000
0.8717%
$25.62$5.12M+61.33%
2019-06-06SaleCardlytics, Inc.
CDLX
10 percent owner
610
0.0027%
$25.00$15,250+70.29%
2019-06-05SaleCardlytics, Inc.
CDLX
10 percent owner
77,202
0.3378%
$24.86$1.92M+66.83%
2019-06-04SaleCardlytics, Inc.
CDLX
10 percent owner
72,756
0.3204%
$23.28$1.69M+79.02%
2019-05-28SaleCardlytics, Inc.
CDLX
10 percent owner
200,000
0.8607%
$23.04$4.61M+72.4%
2018-09-13SaleCardlytics, Inc.
CDLX
100,000
0.4784%
$25.56$2.56M-24.65%
2018-09-12SaleCardlytics, Inc.
CDLX
200,000
0.9309%
$24.78$4.96M-24.38%
2017-11-20PurchaseX4 Pharmaceuticals, Inc.
XFOR
10 percent owner
1M
33.541%
$10.00$10M-10.41%
2015-02-02SaleOcular Therapeutix, Inc.
OCUL
10 percent owner
1M
4.5025%
$29.50$29.5M-32.31%
2014-08-14SaleTrevena, Inc.
TRVN
director
73,404
0.2812%
$6.04$443,360-0.42%
2014-08-13SaleTrevena, Inc.
TRVN
director
11,400
0.0438%
$6.12$69,768-1.41%
2014-04-15PurchaseDaré Bioscience, Inc.
DARE
10 percent owner
2.94M
18.5886%
$7.00$20.59M-11.59%
2014-02-05SaleTrevena, Inc.
TRVN
director
974,264
–
$1.13$1.1M-14.1%
Stocks ScreenerTop-50 StocksInsiders ScreenerList of All Stocks
About Prismo.proPrivacy PolicyTerms of ServiceContact Us